eScholarship
metadata only
CC BY
Multilocus genetic profiling to empower drug trials and predict brain atrophy
Designers of clinical trials for Alzheimer's disease (AD) and mild cognitive impairment (MCI) are actively considering structural and functional neuroimaging, cerebrospinal fluid and genetic biomarkers to reduce the sample sizes needed to detect therapeutic effects. Genetic pre-selection, however, h
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genetic loci of beta-aminoisobutyric acid are associated with aging-related mild cognitive impairment#1263458
- Phenotype, Genotype & Biomarkers in ALS and Related Disorders#1349898
- The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease#1212644
- Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer’s disease#1175109
- Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices#810909
Record · ID 1250153
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive